Quell will no longer be available without a prescription after September 30. Quell Update Notice

What is Quell Therapy Autopilot™?

10/06/2020 • Shai Gozani M.D., Ph.D.

Tags: , , ,

Quell mobile app screens for configure Therapy Autopilot

The stimulation intensity that is required for pain relief and comfort is not constant.  It changes during the course of a 60-minute therapy session and over the course of the day and night.

In a typical TENS device, you must manually adjust the intensity to maintain the right level of nerve stimulation.  This requires your constant vigilance.  We believe that modern pain relief technology should do its job so that you can do yours and live your life.

Quell Therapy Autopilot technology is a patented, automated intensity control that is only found in Quell pain relief devices. Like cruise control on your car, this technology automatically manages stimulation intensity for you, while allowing you to take over at any time.

You can customize Therapy Autopilot to your preferences using the Quell mobile app.


Automatic start Starts a therapy session automatically within a minute of placing the device on your leg.
Intensity ramp up Automatically and comfortably increases the intensity to your therapeutic level at the start of a session.
Desensitization adjustment Slowly increases intensity during the course of the 1-hour session to offset nerve desensitization.
Body position adjustment Intensity automatically adjusts so that stimulation feels consistent when you are lying down.
Time of day adjustment Automatically adjusts intensity so that stimulation feels consistent throughout the day.
Sleep modes Select your preferred style of therapy while you sleep. Options include therapy as you fall asleep, therapy throughout the night at a reduced intensity and therapy when you are experiencing restless sleep.

About The Author
Shai Gozani M.D., Ph.D.

Dr. Gozani is an expert in non-invasive neurostimulation. He received his M.D. degree from Harvard Medical School and the Harvard-MIT Division of Health Science and Technology. Dr. Gozani earned his Ph.D. in Neurobiology, M.S. in Electrical Engineering & Computer Science and B.A. in Computer Science from the University of California at Berkeley. Following his studies, Dr. Gozani conducted post-doctoral research at Harvard Medical School and MIT. He holds 36 U.S. patents and has authored over 30 articles in scientific and clinical peer-reviewed journals. Dr. Gozani is founder, president and CEO of NeuroMetrix, Inc.; which designs and manufactures Quell.

Subscribe to the Living Quell Blog

Sign up for the Living Quell Blog and get the best content delivered to your inbox weekly.